About this Medicine article
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial by Lieverse, Relinde I. Y.; Van Limbergen, Evert J.; Oberije, Cary J. G.; Troost, Esther G. C.; Hadrup, Sine R.; Dingemans, Anne-Marie C.; Hendriks, Lizza E. L.; Eckert, Franziska; Hiley, Crispin; Dooms, Christophe; Lievens, Yolande; de Jong, Monique C.; Bussink, Johan; Geets, Xavier; Valentini, Vincenzo; Elia, Giuliano; Neri, Dario; Billiet, Charlotte; Abdollahi, Amir; Pasquier, David; Boisselier, Pierre; Yaromina, Ala; De Ruysscher, Dirk; Dubois, Ludwig J.; Lambin, Philippe is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Lieverse, Relinde I. Y.; Van Limbergen, Evert J.; Oberije, Cary J. G.; Troost, Esther G. C.; Hadrup, Sine R.; Dingemans, Anne-Marie C.; Hendriks, Lizza E. L.; Eckert, Franziska; Hiley, Crispin; Dooms, Christophe; Lievens, Yolande; de Jong, Monique C.; Bussink, Johan; Geets, Xavier; Valentini, Vincenzo; Elia, Giuliano; Neri, Dario; Billiet, Charlotte; Abdollahi, Amir; Pasquier, David; Boisselier, Pierre; Yaromina, Ala; De Ruysscher, Dirk; Dubois, Ludwig J.; Lambin, Philippe
- Publisher
- BioMed Central; Springer (Biomed Central Ltd.); London: BioMed Central, [2001]-; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1471-2407)
- Published
- 2020
- Field
- Medicine (Health Sciences)